Search fresh public links, source activity, and post angles for Biocon Share.
Fresh curated links around Biocon share are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Biocon: Nuvama said Q4FY26 growth moderated as Biocon upgraded facilities to scale up capacity in response to anticipated demand in the US and Europe.
Synopsis: Biocon Limited received Health Canada approval for Bosayaâ„¢ and Vevzuoâ„¢, denosumab biosimilars for osteoporosis and cancer-related bone conditions, expanding global re...
Synopsis: Biocon Limited received Health Canada approval for Bosayaâ„¢ and Vevzuoâ„¢, denosumab biosimilars for osteoporosis and cancer-related bone conditions, expanding global re...
Synopsis: With a debt-free balance sheet and steady cash flows, Windlas Biotech Limited has informed exchanges that its board will meet on April 17, 2026, to consider an equity sha...
Synopsis: The Hyderabad-based pharma giant has given the green light to repurchase shares at ₹1,475 each, a 10% premium over the current market price. A major Indian pharma giant...
Synopsis: Konstelec Engineers Limited has emerged as the lowest (L1) bidder for three projects totalling approximately Rs. 165.85 crore, awarded by Numaligarh Refinery Limited and...
Synopsis: This is a crucial corporate development update related to Windlas Biotech Limited. As per this, the company’s Board of Directors has formally authorized a massive buyback...
The stock climbed 5.37 per cent to hit an intraday high of Rs 4,194.40 on BSE, just shy of its 52-week high of Rs 4,200 touched earlier this year on February 4. The scrip eventuall...
Other pharma stocks, including Wockhardt Ltd, Lupin Ltd, Divi's Laboratories Ltd, Zydus Lifesciences Ltd, Torrent Pharmaceuticals Ltd, JB Chemicals & Pharmaceuticals Ltd, Manki...
Synopsis: Cohance Lifesciences Ltd hit an upper circuit of Rs 380.2 today, a 19.27 percent surge backed by a 15-fold volume explosion and delivery volumes up 398 percent over the f...
Synopsis: Dr. Reddy’s Laboratories has received a strategic boost after its partner secured Health Canada approval for Semaglutide Injection, strengthening its position in the high...
Synopsis: The share of this company fell after Q4 FY26 results, despite announcing a 9,050 percent final dividend, as mixed earnings and margin pressure weighed on sentiment. The s...
Analysts share their views on navigating the latest trends in Asian Paints, Dixon Tech, and India's capital market stocks.
Axis Direct said that V2 Retail has regained the buying momentum around the 200-day SMA support zone of Rs 204 on the daily charts, which remains a crucial support level.
Synopsis:- Brokerage maintains a ‘Buy’ with Rs 600 target, implying 31% upside from Rs 457, backed by strong volume growth and margin expansion. Market share remains below 10% in a...
Synopsis: The share of this company jumped 15.1 after strong Q4 results, driven by sharp profit expansion, robust poultry healthcare growth, and improved margins, alongside a major...
The company has fixed April 17, 2026, as the record date to determine the eligibility of shareholders who can participate in the buyback.
Synopsis: Kalyani Investment Company Limited reported a strong performance in Q4 FY26, driven by higher dividend income, gains from investments, and a sharp recovery in associate c...
Synopsis: Plastiblends India Limited has announced its Q4 FY26 results, reporting revenue of Rs. 214.3 crore (6.3% YoY) and net profit of Rs. 13.9 crore (44.8% YoY). The company al...
नई दिल्ली: भारत की मशहूर Biotech Entrepreneur Kiran Mazumdar-Shaw ने अपनी कंपनी के भविष्य को लेकर बड़ा कदम उठाया है। उन्होंने अपनी भतीजी Claire Mazumdar को अपना उत्तराधिकारी चुना ह...
Cipla share price today: Cipla shares rose 11% in two sessions from Rs 1292 on May 12 to Rs 1432 in the current session. In today's session, the stock surged 8% intra day. Market...
Dividend history: Before this upcoming payout, the company distributed an interim dividend of Rs 6 per share on October 17, 2025. Prior to that, a final dividend of Rs 7 on May 9,...
Synopsis: The share jumps 11 percent on strong Q4 performance, driven by robust ANDA (Abbreviated New Drug Application) pipeline and 385 percent growth in branded generics, signall...
Synopsis: Hester Biosciences Limited reported a strong performance in Q4 FY26, driven by sharp improvement in profitability and healthy growth in revenue. The company posted consol...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.